S2095 HCPCS Level II code: Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres
S2095 is the HCPCS code for “Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
S2095Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres
Short description: Transcath emboliz microspher
HCPCS · United States
Medicare details
The indicators CMS publishes with S2095 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Not payable by Medicare
- Medicare pricing
- Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
- Type of service
- Other medical items or services
- BETOS category
- Undefined codes
- Added
- Jan 1, 2004
Where S2095 sits
- 1S codesTemporary national codes (non-Medicare)
- 2Active code S2095Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code S2095 mean?
S2095 is the HCPCS code for “Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover S2095?
CMS lists S2095’s Medicare coverage as “Not payable by Medicare” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside S2095
All S codesS2067Breast reconstruction of a single breast with "stacked" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of…S2068Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular…S2070Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)S2079Laparoscopic esophagomyotomy (heller type)S2080Laser-assisted uvulopalatoplasty (laup)S2083Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of salineS2102Islet cell tissue transplant from pancreas; allogeneicS2103Adrenal tissue transplant to brainS2107Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatmentS2112Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)S2115Osteotomy, periacetabular, with internal fixationS2117Arthroereisis, subtalar